Takayuki Shiroyama

9PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityRespiratory diseasesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
Systemic therapy for advanced thymic epithelial tumors: a narrative review of current evidence and perspectives.

|Apr 21, 2026
Authors' Reply to Letter to the Editor: Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors.

|Jan 05, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.

Makoto Nishio, Shuji Murakami, Hisato Kawakami

|Feb 28, 2022
COVID-19 in a human T-cell lymphotropic virus type-1 carrier.

Takatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata

|Jan 14, 2022
Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report.

Kinnosuke Matsumoto, Takayuki Shiroyama, Kotaro Miyake

|Jun 17, 2021
Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19.

Saori Amiya, Haruhiko Hirata, Takayuki Shiroyama

Pageof 2

Frequent Collaborators

1 joint publications

Shohei Koyama

1 joint publications

Masaki Kanazu

1 joint publications

Kinnosuke Matsumoto

1 joint publications

Takatoshi Enomoto